Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2022

Open Access 01-12-2022 | Position statement

Rare diseases in Tanzania: a National Call for Action to address policy and urgent needs of individuals with rare diseases

Authors: Frida Kaywanga, Mohamed Zahir Alimohamed, Aneth Bella David, Daniel Maeda, Sharifa Mbarak, Togolani Mavura, Siana Nkya, Deus S. Ishengoma

Published in: Orphanet Journal of Rare Diseases | Issue 1/2022

Login to get access

Abstract

A rare disease is generally defined as a condition which affects about 1 among 2000 people and currently, there are approximately 5000–8000 rare diseases (RDs) affecting over 400 million people world-wide. Although RDs may arise from different causes such as infections and environmental factors, about 80% are caused by genetic abnormalities. In Tanzania, there are no reports of the types of RDs, their incidence, distribution and numbers of individuals affected. In addition, there have been no strategies to map RDs in the country and develop a definition that fits the local context. Public awareness and understanding of RDs are very limited, and these lead to poor management and stigmatisation of patients. To address the ongoing problems, Tanzania joined other countries world-wide and global partners to commemorate the rare diseases day (RDD) for the first time in 2016 and subsequently every year. Unlike previous years where the RDD was organised by Ali Kimara Rare Diseases Foundation (AKRDF) with few partners, in 2020, a bigger event was co-hosted by Ali AKRDF and Tanzania Human Genetics Organization together with government representatives and other multiple partners. The organisers, government representatives and participants proposed a national “Call for Action” with the overall goal of improving the lives of patients/individuals with RDs. The call focuses and aims to address 17 strategic issues that are broadly categorised into four areas. These include generating demographic data of individuals with RDs; advocating for policies and guidelines for diagnosis, care, treatment and health financing; developing policies supporting public education, awareness and advocacy; and strengthening research, innovation and public–private partnerships. If adopted and implemented, the potential impacts of these recommendations will include improved access to adequate and high-quality health and education services, and policies and guidelines to address the current and future challenges facing individuals with RDs and their families.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference EURORDS. What is a rare disease? 2022. 3-7-2022. EURORDS. What is a rare disease? 2022. 3-7-2022.
3.
go back to reference Lee CE, Singleton KS, Wallin M, Faundez V. Rare genetic diseases: nature’s experiments on human development. iScience. 2020;23:101123.CrossRef Lee CE, Singleton KS, Wallin M, Faundez V. Rare genetic diseases: nature’s experiments on human development. iScience. 2020;23:101123.CrossRef
4.
go back to reference Adler A, Kirchmeier P, Reinhard J, Brauner B, Dunger I, Fobo G, et al. PhenoDis: a comprehensive database for phenotypic characterization of rare cardiac diseases. Orphanet J Rare Dis. 2018;13:22.CrossRef Adler A, Kirchmeier P, Reinhard J, Brauner B, Dunger I, Fobo G, et al. PhenoDis: a comprehensive database for phenotypic characterization of rare cardiac diseases. Orphanet J Rare Dis. 2018;13:22.CrossRef
5.
go back to reference Baynam GS, Groft S, van der Westhuizen FH, Gassman SD, du Plessis PK, Coles EP, et al. A call for global action for rare diseases in Africa. Nat Genet. 2020;52:21–6.CrossRef Baynam GS, Groft S, van der Westhuizen FH, Gassman SD, du Plessis PK, Coles EP, et al. A call for global action for rare diseases in Africa. Nat Genet. 2020;52:21–6.CrossRef
6.
go back to reference United Nations. UN resolution on addressing the challenges of persons living with a rare disease and their families. 2021. 3-7-2022. United Nations. UN resolution on addressing the challenges of persons living with a rare disease and their families. 2021. 3-7-2022.
7.
go back to reference Ramalle-Gomara E, Dominguez-Garrido E, Gomez-Eguilaz M, Marzo-Sola ME, Ramon-Trapero JL, Gil-de-Gomez J. Education and information needs for physicians about rare diseases in Spain. Orphanet J Rare Dis. 2020;15:18.CrossRef Ramalle-Gomara E, Dominguez-Garrido E, Gomez-Eguilaz M, Marzo-Sola ME, Ramon-Trapero JL, Gil-de-Gomez J. Education and information needs for physicians about rare diseases in Spain. Orphanet J Rare Dis. 2020;15:18.CrossRef
8.
go back to reference Vandeborne L, van Overbeeke E, Dooms M, De Beleyr B, Huys I. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis. 2019;14:99.CrossRef Vandeborne L, van Overbeeke E, Dooms M, De Beleyr B, Huys I. Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis. 2019;14:99.CrossRef
9.
go back to reference A six-year-old with a rare disease finds answers—and treatment. 2019. 3-7-2022. A six-year-old with a rare disease finds answers—and treatment. 2019. 3-7-2022.
10.
go back to reference Sieberg CB, Lebel A, Silliman E, Holmes S, Borsook D, Elman I. Left to themselves: time to target chronic pain in childhood rare diseases. Neurosci Biobehav Rev. 2021;126:276–88.CrossRef Sieberg CB, Lebel A, Silliman E, Holmes S, Borsook D, Elman I. Left to themselves: time to target chronic pain in childhood rare diseases. Neurosci Biobehav Rev. 2021;126:276–88.CrossRef
11.
go back to reference Graf von der Schulenburg JM, Frank M. Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems. Eur J Health Econ. 2015;16:113–8.CrossRef Graf von der Schulenburg JM, Frank M. Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems. Eur J Health Econ. 2015;16:113–8.CrossRef
12.
go back to reference Luzzatto L, Makani J. Treating rare diseases in Africa: the drugs exist but the need is unmet. Front Pharmacol. 2021;12: 770640.CrossRef Luzzatto L, Makani J. Treating rare diseases in Africa: the drugs exist but the need is unmet. Front Pharmacol. 2021;12: 770640.CrossRef
13.
go back to reference Costa E, Schieppati A, Luzzatto L, Remuzzi G. Drugs for rare diseases: the blessing of being orphans. Recenti Prog Med. 2019;110:221–9.PubMed Costa E, Schieppati A, Luzzatto L, Remuzzi G. Drugs for rare diseases: the blessing of being orphans. Recenti Prog Med. 2019;110:221–9.PubMed
14.
go back to reference Alimohamed MZ, Mwakilili AD, Mbwanji K, Manji ZK, Kaywang F, Mwaikono KS, et al. Inauguration of the Tanzania Society of Human Genetics: biomedical research in Tanzania with emphasis on human genetics and genomics. Am J Trop Med Hyg. 2020;104:474–7.CrossRef Alimohamed MZ, Mwakilili AD, Mbwanji K, Manji ZK, Kaywang F, Mwaikono KS, et al. Inauguration of the Tanzania Society of Human Genetics: biomedical research in Tanzania with emphasis on human genetics and genomics. Am J Trop Med Hyg. 2020;104:474–7.CrossRef
15.
go back to reference TMDA. Tanzania food, drugs and cosmetics (orphan medicines). 2018. 3-7-2022. TMDA. Tanzania food, drugs and cosmetics (orphan medicines). 2018. 3-7-2022.
16.
17.
go back to reference Dunkle M. A 30-year retrospective: National Organization for Rare Disorders, the Orphan Drug Act, and the role of rare disease patient advocacy groups. Orphan Drugs Res Rev. 2014;4:19–27.CrossRef Dunkle M. A 30-year retrospective: National Organization for Rare Disorders, the Orphan Drug Act, and the role of rare disease patient advocacy groups. Orphan Drugs Res Rev. 2014;4:19–27.CrossRef
18.
go back to reference EUR-Lex. Medicines for rare diseases—orphan drugs. 2000. 25-7-2022. EUR-Lex. Medicines for rare diseases—orphan drugs. 2000. 25-7-2022.
19.
go back to reference EUR-Lex. Report from the commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Implementation Report on the Commission Communication on Rare Diseases: Europe's challenges [COM(2008) 679 final] and Council Recommendation of 8 June 2009 on an action in the field of rare diseases (2009/C 151/02). 2014. 25-7-2022. EUR-Lex. Report from the commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions Implementation Report on the Commission Communication on Rare Diseases: Europe's challenges [COM(2008) 679 final] and Council Recommendation of 8 June 2009 on an action in the field of rare diseases (2009/C 151/02). 2014. 25-7-2022.
20.
go back to reference India Ministry of Health and Family Welfare. Union Santé Minister approves National Policy for Rare Diseases, 2021. 2021. 3-7-2022. India Ministry of Health and Family Welfare. Union Santé Minister approves National Policy for Rare Diseases, 2021. 2021. 3-7-2022.
Metadata
Title
Rare diseases in Tanzania: a National Call for Action to address policy and urgent needs of individuals with rare diseases
Authors
Frida Kaywanga
Mohamed Zahir Alimohamed
Aneth Bella David
Daniel Maeda
Sharifa Mbarak
Togolani Mavura
Siana Nkya
Deus S. Ishengoma
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2022
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-022-02498-0

Other articles of this Issue 1/2022

Orphanet Journal of Rare Diseases 1/2022 Go to the issue